Screening | 2 weeks within randomization | 1 months after end of RT | 3 months after end of RT | Every 3 months | 12 months after end of RT | Every year | Biochimical relapse | Clinical relapse | |
---|---|---|---|---|---|---|---|---|---|
Physical examination | x | x | x | ||||||
PSA/testosterone | x | x | x | x | |||||
GS | x | ||||||||
Previous treatments for PCa | x | ||||||||
ECOG score | x | ||||||||
Comorbidities | x | ||||||||
Imaging | x | ||||||||
Blood tests (NLR) | x | ||||||||
Serum and plasma collection | x | x | x | ||||||
Acute toxicity assessment | x | ||||||||
Late toxicity assessment | x | ||||||||
QoL | x | x | x | x | x | ||||
Cho-PET/TC or RM-WB | x | x |